Figure 1: Effects of LEM jelly on postprandial glucose and insulin levels in patients with type 2 diabetes treated with or without SU. Data were expressed as means ± SD (SU-treated, n=5; SU-untreated, n=5). a, c: Postprandial glucose and insulin levels were significantly suppressed by ingestion of jelly containing LEM, compared to the ingestion of placebo jelly in patients receiving SU; p<0.05 by paired Student’s t-test. b, d: Significant differences were also observed in the postprandial glucose and insulin responses in patients not treated with SU; p<0.05 by paired Student’s t-test. *There was a significant difference in insulin levels between SU-treated and SU-untreated patients after ingestion of placebo jelly; p<0.05 by Student’s t-test.